Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | AMPHAmphastar Pharmaceuticals, Inc.FY2025 · Dec |
|---|---|
| Revenue | $719.89M |
| Revenue, yoy | −1.7% |
| Net income | $98.09M |
| Net income, yoy | −38.5% |
| Net margin | 13.6% |
| Free cash flow | $121.23M |
| FCF margin | 16.8% |
| EPS, diluted | $2.03 |
Add another company.